ABSTRACT
INTRODUCTION
The occurrence of the DNA in nucleosomes restricts the access of DNA-binding proteins to their specific sequences, a fact with potentially serious implications for the transcription process in eukaryotic nuclei (reviewed in 1). However, until recently there was no clear indication of how the impediment caused by the presence of nucleosomes is dealt with during transcription in vivo. The specialised transcription factors could themselves open up the chromatin structure, for example by competing with nucleosomes, without the need for any 'derepressing' factors or there could be unique mechanisms destabilising nucleosomal structure before the real transcriptional initiation could take place. While there is strong evidence that in the case of some sequences like the yeast PH05 gene promoter, the recruitment of the RNA polymerase II holoenzyme is itself sufficient to remodel chromatin for efficient transcription (2) , in the case of certain other genes, like yeast HO and SUC2, the presence of specialised chromatin remodelling complex is required for activation (3, 4) .
Of several protein complexes with reported chromatin remodelling activity, the SWI/SNF complex is by far the best characterised (reviewed in 5, 6) . In Saccharomyces cerevisiae, the products encoded by SWI1, SWI2 (SNF2), SWI3, SNF5 and SNF6 genes were originally identified as positive regulators of HO and SUC2 genes and later found to play the same role in the transcription of other diversely regulated genes. The functional interdependence between the five proteins strongly suggested that they act jointly as a complex. This was confirmed by the biochemical studies which led to the isolation of a large (∼2 MDa) complex containing all five proteins plus additional polypeptide components. The ability of SWI/SNF complex to alter the structure of chromatin was demonstrated by in vitro experiments with reconstituted nucleosomes. The complex was capable of destabilising DNA-histone interactions in nucleosomes in an ATP-dependent manner. The destabilisation, the molecular basis of which is still not clear, led to the increased binding to specific sequences in nucleosomal DNA of transcription factors, such as GAL4 derivatives or the TATA-box binding protein. The genes homologous to those coding for yeast SWI/SNF proteins have been identified in Drosophila (7), mouse (8) and human (9, 10) . Brahma is a Drosophila homologue of SWI2/SNF2. Two human genes highly similar to SWI2/SNF2 are Brg1 and hBrm, named for their similarity to the Drosophila Brahma. Immunoprecipitation with antibodies to BRG1 and hBRM proteins enabled the isolation of two chromatographically distinct multiprotein complexes termed hSWI/SNF A and hSWI/SNF B, both of which were capable of destabilising nucleosome structure and facilitating the binding of GAL4 derivatives in an ATP-dependent manner (11, 12) . The other components of the human homologue of SWI/SNF complex are probably also similar to their yeast counterparts. The human INI1 gene shows high similarity to yeast SNF5p and the INI1 protein cofractionates with hSWI/SNF and associates with BRG1 (13) . In Drosophila, a protein homologous to yeast SNF5p is encoded by a snr1 gene. Both the Brahma and SNR1 proteins are components of a large multiprotein complex and co-immunoprecipitate from Drosophila extracts (14) .
In this paper we describe the isolation of a plant (Arabidopsis thaliana) cDNA encoding a protein with high homology to yeast SNF5p, human INI1 and Drosophila SNR1 proteins as well as to the other putative SNF5-type proteins. With 240 amino acids, the Arabidopsis homologue of yeast SNF5, which we named BSH (for bushy growth exhibited by mutants deficient in BSH mRNA), is the smallest SNF5-type protein so far identified. The BSH gene partially complements the snf5 mutation in yeast. However, BSH, unlike yeast SNF5p and human INI1, is unable to activate transcription in yeast when tethered to DNA. We show that BSH mRNA is ubiquitously expressed in plant and that BSH protein is localised in nuclei.
MATERIALS AND METHODS

Cloning of BSH cDNA, Southern and northern blot analysis
The A.thaliana cDNA libraries λPRL-2 (15), λgt10 siliques library and λZAPII (16) were obtained from Arabidopsis Biological Resource Centre, OH, USA. The libraries were screened by plaque hybridisation using the probe generated with PCR with primers U1: GAA AGG TCC CGT CAA GTT and L1: TCA TAA GCC CGA AAG TCT, designed on the basis of the A.thaliana EST sequence found in GenBank. PCR conditions were as follows: 95_C for 5 min, 30× (52_C for 30 s, 72_C for 30 s, 95_C for 30 s), 52_C for 30 s, 72_C for 2 min. The PCR product obtained from cDNA generated with the Gibco BRL RT kit on the total RNA isolated from A.thaliana, was reamplified with the same set of primers and the PCR DIG labelling nucleotide mix (Boehringer) and used as a probe. After three rounds of screening of λgt10 siliques library a single positive clone was found. The cDNA was excised from this clone with SalI and inserted into a Bluescript KS (Stratagene) plasmid resulting in the pS5c10 plasmid, and sequenced on both strands by the dideoxy method using ALF (Pharmacia) DNA sequencer. Total genomic DNA was prepared from leaves as described (17) . Southern blot hybridisation with the DIG labelled probe used for screening cDNA libraries (see above) was according to (18) . For northern blot analysis total RNA was extracted from flowers and siliques of Arabidopsis by the method of Verwoerd (19) , electrophoresed in formaldehyde containing gel and transferred onto a membrane. The membrane was hybridised with DIG labelled (Boehringer labelling kit) antisense RNA probe corresponding to a full-length cDNA, by the method of Engler-Blum (18) . To visualise the bound probe a CDP-Star chemiluminescent AP substrate (Boehringer) was used.
Transcription activation assay
The PCR product amplified from pS5C10 with primers U2 (CGC CCT GAT AGA CGG TTT TTC GCC CTT TGA) and L2 (GGA TCC CTA GTG ATG GTG ATG GTG ATG TCT CTC TTC CCT GGC TTC AAG) comprised a full-length BSH coding sequence with six histidine codons and STOP codon added on the 3′ end by L2 primer and a part of the vector. The conditions of PCR were as follows: 95_C for 5 min, 30× (60_C for 30 s, 72_C for 1 min, 95_C for 30 s), 60_C for 30 s, 72_C for 5 min. The DNA fragment was cut with EcoRV and BamHI and inserted into SmaI and BamHI sites of the pGBT9 plasmid (Clontech) resulting in the pGBSH6 plasmid. The PCR was done with Pfu DNA polymerase (Stratagene) to ensure high fidelity. The correctness of the BSH sequence in the GAL4 -BSH fusion was checked by DNA sequencing. The pGBSH6 plasmid was transformed into the Y190 (Clontech) yeast reporter strain. Expression of the GAL4 1-147 -BSH fusion protein was checked by western blot with α-GAL4DB antibody (Santa Cruz Biotechnology). The level of β-galactosidase activity was measured by replica lift method and by colorimetric method as described in the Clontech yeast techniques manual. As controls, the Y190 strain was transformed with pGBT9 alone and with the pCL1 plasmid (20) to express the full-length GAL4 protein.
Complementation of yeast snf5 mutant strain
The PCR product amplified from the pS5c10 plasmid with a primer to the linker sequence of the pBluescript plasmid and the L2 primer was cut with SacI and BamHI and inserted into the pSI4 yeast multicopy expression vector resulting in the pSIBSH plasmid in which the expression of a cloned gene is driven by the CAT1 inducible promoter. The phenotypes of the yeast snf5 strain MCY1991 (21) after transformation with the pSIBSH, empty pSI4 and pJW34 (4) derivative bearing the yeast SNF5 gene, were checked on glucose and galactose.
Analysis of BSH expression by RT-PCR
RNA was extracted from roots, stalks, pods, flowers and siliques of A.thaliana plants grown on the MS medium, by the method of Verwoerd (19) . After treating with DNase I (Promega) the RNA was used for generation of cDNA using Gibco BRL RT kit according to the manufacturer's instructions. The PCR was done with L1 and U1 primers. As a control the fragment of A.thaliana protein kinase 1 (atpk1) cDNA (22) was amplified with primers KIN1 (AAA CAA CAA CCA AAG AAG) and KIN2 (AAA CCC GAA AAC ATA CTC), using the same conditions.
Production of anti-BSH antibodies
Recombinant BSHis 6 EC protein containing amino acids 1-238 of BSH with six histidines fused to the C-terminus was overproduced in Escherichia coli SG 13009 cells using the pQE60 plasmid of the QIAExpress system (Qiagen) and purified by selective binding to NiNTA (Qiagen) followed by elution according to manufacturer's protocol. The final preparation (∼1 mg of protein) was separated by preparative SDS-PAGE. Gel fragments containing pure BSHis 6 EC were used to immunise rabbits. Anti-BSHis 6 EC rabbit serum was prepared by Eurogenetec (Seraing, Belgium).
Protein extraction and immunoblot analyses
Total protein extracts were prepared from whole A.thaliana plants according to Foster et al. (23) . Briefly, 50 g of frozen plant material was pulverised in a mortar and homogenised with 150 ml of extraction buffer (15 mM HEPES-KOH, pH 7.6, 40 mM KCl, 5 mM MgCl 2 , 1 mM DTT, 0.1 mM PMSF). 4 M ammonium sulphate was then added dropwise with constant stirring. After 30 min the mixture was centrifuged in a Beckman SW 28 rotor at 19 000 r.p.m. and the supernatant was filtered through miracloth. Protein was precipitated from the filtrate by raising the concentration of ammonium sulphate to 0.33 g/ml and centrifuging the mixture for 30 min in a Beckman Ti 70 rotor at 19 000 r.p.m. The pellet was suspended in 2 ml of a buffer containing 20 mM HEPES-KOH, pH 7.6, 40 mm KCl, 1 mM DTT, 0.5 mM PMSF, 0.1 mM EDTA, 10% glycerol and dialysed for 3 h against 20 mM HEPES-KOH, pH 7.6, 40 mM KCl, 0.1 mM PMSF, Nucleic Acids Research, 1999 , Vol. 27, No. 11 2395 0.1 mM EDTA, 5 mM β-mercaptoethanol, 10% glycerol. All procedures were carried out at 4_C.
Extracts of nuclear proteins were obtained as follows. Plants were cut into small fragments and homogenised for 15 s in 5 vol of NIB buffer (0.33 M sucrose, 10 mM NaCl, 10 mM KCl, 10 mM β-mercaptoethanol, 2.5 mM EDTA, 0.1 mM spermine, 0.5 mM spermidine, 10 mM MES-KOH, pH 6.3). After filtration through four layers of gauze the subcellular organelles were pelleted from the filtrate by centrifugation for 10 min in an HB4 (Sorvall) rotor at 4000 r.p.m. The pellet was suspended in NIB buffer. In order to achieve the lysis of chloroplasts 10% Triton X-100 was slowly added to the suspension until the final concentration of 0.2%. After 5 min incubation the suspension was centrifuged as above and washed with NIB buffer. The final pellet was suspended in a small volume of NEB buffer (15 mM HEPES-KOH, pH 7.5, 110 mM KCl, 5 mM MgCl 2 , 1 mM DTT) and incubated on ice for 30 min. During incubation NaCl was slowly added to the final concentration of 0.42 M. The suspension was then centrifuged for 30 min at 60 000 g. To the supernatant which contained the nuclear extract, ammonium sulphate was added to a final concentration of 80%. After centrifugation of the precipitate the pellet consisting of nuclear proteins was suspended in Z buffer (25 mM HEPES-KOH, pH 7.5, 70 mM KCl, 0.1 mM EDTA, 20% glycerol, 1 mM DTT) and dialysed for 2 h against 1000 vol of the same buffer with four changes. All procedures were at 4_C.
Protein samples were electrophoresed through 12% SDSpolyacrylamide gels according to (24) , and transferred by electroblotting to PVDF membrane (Immobilon P, Milipore). Filters were blocked for 30 min at room temperature in Blotto A (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5% non-fat dry milk). Incubation with rabbit anti-BSH serum was carried out in Blotto A blocking buffer for 45 min. The filters were washed twice with TBS (10 mM Tris-HCl, pH 8.0, 150 mM NaCl) and incubated for 1 h with alkaline phosphatase-conjugated goat anti-rabbit secondary antibody (DAKO) at a dilution of 1:1000 in Blotto A. The detection was with BCIP and NBT (Boehringer, Mannheim) colorimetric substrates.
Construction and analysis of transgenic plants
The plant integration plasmid pROKBSH was constructed by inserting the SalI fragment of pS5c10, in an antisense orientation, into the pROKF19 plasmid (25) in which the expression of the inserted gene is driven by an enhanced CaMV35S viral promoter. The transformation of Arabidopsis roots was according to Valvekens et al. (26) . Transgenic plants were selected on the MS-kanamycine medium and regenerated on the MS medium. The RNA was extracted from plants obtained upon transformation with pROKBSH or with pROKF19 (control) by the method of Verwoerd (19) . The RNA was subjected to DNase treatment and quantified spectrophotometrically. RNA samples (20 µg) were loaded into slots and the level of the BSH expression was analysed by slot-blot hybridisation with the DIG labelled antisense RNA probe specific for the BSH mRNA.
Nucleotide sequence accession number
The cDNA sequence of A.thaliana BSH has been deposited in GenBank under accession no. U88061.
RESULTS
Identification of a plant homologue of yeast SNF5 gene
In an attempt to identify plant counterparts to the genes coding for the components of yeast SWI/SNF complex we searched the A.thaliana dbEST database. This search revealed a single cDNA sequence of 340 nt with homology to S.cerevisae SNF5. Using a PCR amplified fragment of this cDNA as a probe, we screened the A.thaliana cDNA library. Screening of 2 × 10 6 plaques yielded a single positive clone containing an 876 nt cDNA insert, which we sequenced. The 876 nt cDNA contains an open reading frame (ORF) encoding a predicted 240-amino acid protein (DDBJ/EMBL/GenBank accession no. U88061). The end of the ORF is marked by the STOP codon followed by the 3′ untranslated region (UTR) that ends with a poly(A) tract. There is no typical AATAAA polyadenylation signal in the 3′ UTR. However, in plants the sequence requirement for polyadenylation is in general less stringent than in animal cells (27) . The perfect copies of the AATAAA sequence are found upstream of the polyadenyl-ation site in less than one-half of all plant genes examined (28) . Although in the cloned cDNA there is no in-frame translation termination codon preceding the first methionine, we have good reason to believe that the first methionine indeed marks the start of the complete ORF. The size of the cloned cDNA corresponds to that of the single mRNA band revealed by the specific probe on the northern blot performed with the total A.thaliana RNA (Fig. 2B) , and the initial AUG resides in a sequence that conforms to the Kozak consensus (29) . The sequence comparison of the predicted A.thaliana protein with Drosophila, human and fish homologues of SNF5 reveals significant similarity in all four proteins of the conserved N-terminal stretch (Fig. 1B) . In addition, the comparison by BLAST of the ORF in the sequence upstream of the BSH putative AUG start codon revealed no homology with the Box C of the known members of the SNF5 family and in fact with no other protein sequence contained in databases. We named the A.thaliana protein BSH after the bushy phenotype of the Arabidopsis (described later in the Results) caused by the decreased level of the BSH transcript.
Comparison of the predicted sequence of the Arabidopsis BSH protein with known sequences in the databases revealed a significant match only to seven proteins: S.cerevisiae SNF5p and its homologues from human (INI1) and Drosophila (SNR1) cells, the second S.cerevisiae SNF5-type protein (ySNF5bp or SFH1) and the proteins from Caenorhabditis elegans (CeSNF5), fish (TfSNF5) and Schizosaccharomyces pombe (SpSNF5)-all members of the SNF5-type family. The alignment of all eight proteins reveals two regions of close similarity: the SNF5 domain and the B Box (Fig. 1A and B) . The most significant is the similarity in the SNF5 domain, a characteristic distinction of the SNF5 family of proteins.
In BSH the SNF5 domain contains 137 residues. It spans from amino acid 21 to 158 and has two characteristic subregions similar to those occurring in SNF5 domains of other members of the family. The first subregion of BSH has 29.4% and the second 39% identical residues with the corresponding subregions of the S.cerevisiae SNF5p. The percentage of identical residues with corresponding subregions of INI1 is 39.2 and 34.4%; SNR1, 41.2 and 34.4%; and SNF5bp, 35.3 and 26.6%. The Arabidopsis BSH has no proline-and glutamine-rich sequences that flank the core SNF-5 domain in the S.cerevisiae SNF5p, but these sequences are (Fig. 1B) with >50% of identical residues. On the basis of the very significant similarities in the core coding region between BSH and all the known representatives of the SNF5 family of proteins, we propose that BSH is an A.thaliana homologue of the S.cerevisiae gene encoding the SNF5 protein. With only 240 amino acids, BSH is the smallest of the known SNF5-type proteins.
BSH is a single copy gene and is ubiquitously expressed in Arabidopsis plant
Southern hybridisation of the BSH cDNA probe with Arabidopsis genomic DNA cut with different restriction enzymes indicates that BSH is a single copy gene ( Fig. 2A) .
To study the expression of the BSH gene in Arabidopsis, the RNA isolated from different organs of the plant was reversetranscribed into cDNA which was then used as template for the PCR reaction with primers specific for a region from the conserved SNF5 domain of the BSH gene. The PCR products of the expected size were detected for each of the tested organs, i.e. roots, stalks, leaves, flowers and pods (Fig. 3A) . A control PCR using the same primers but performed on Arabidopsis genomic DNA resulted in a much larger product (Fig. 3B) . This is consistent with our data showing that the BSH gene contains introns (results not shown). The occurrence of BSH mRNA in all tested plant organs could indicate that the BSH protein is involved in many different processes.
Nuclear localisation of the BSH and its unusual behaviour in SDS-PAGE
To determine whether BSH is a cytoplasmic or nuclear protein we prepared protein extracts from whole cells and from isolated nuclei (Materials and Methods). Identical amounts (20 µg) of proteins from each type of extract were separated by SDS-PAGE, blotted to membrane and probed with polyclonal antibodies raised against recombinant BSH (Materials and Methods). BSH was detected only in the nuclear extract (Fig. 4) indicating that in vivo it is localised in nuclei. Both the recombinant and the native BSH migrate in SDS-PAGE as a 40 kDa protein, i.e. considerably slower than protein of the predicted molecular mass of 27 kDa. This concerns both the recombinant and the native BSH protein (the small difference in mass between the recombinant and native BSH seen on the gel is fully accounted for by the presence of six histidines in the E.coli made protein). We have checked by overexpression in E.coli of the BSH SNF5 domain that the slower mobility of the protein results from the anomalous behaviour of its SNF5 domain (results not shown). In order to eliminate any possibility of an error we confirmed the identity of the overexpressed BSH SNF5 domain by extracting the protein band from SDS gel and performing N-terminal microsequencing. Thus, the characteristic feature of Arabidopsis BSH protein is a anomalous behaviour in SDS-PAGE. Whether this reflects some specific steric properties remains to be checked.
BSH partially complements yeast snf5 mutation but is unable to activate transcription in yeast when tethered to DNA
In order to determine if BSH can functionally replace the yeast SNF5 in vivo, we tested the ability of the Arabidopsis gene to complement the snf5 mutation in S.cerevisiae. The characteristic phenotype caused by snf5 mutation is a weak growth on media with a carbon source other than glucose (4). The yeast strain with the snf5 mutation (MCY 1991) was transformed with the multicopy expression vectors (Materials and Methods) bearing either complete S.cerevisiae SNF5 or Arabidopsis BSH gene. The mutant strain was also transformed with the empty pSI4 vector to serve as control for the snf5 phenotypes. The growth of Figure 5 . BSH partially complements the SNF5 -phenotype of the S.cerevisiae snf5 mutant. Yeast snf5 strain MCY1991 was transformed with pJW34 (SNF5), pSI4 (vector) or pSIBSH (BSH). Five-fold serial dilutions of the transformants were transferred to plates with minimal medium lacking uracil and containing either glucose or galactose. The plates were incubated for 5 days at 30_C and photographed.
transformed strains on media containing glucose or galactose as a carbon source was then examined (Fig. 5 ). All strains grew normally on glucose. On galactose the construct bearing no SNF5-type gene failed to complement the snf5 mutant phenotype. As expected, the ability to grow on galactose was readily restored upon transformation of the tested strain with plasmid bearing the yeast SNF5 gene. Transformation with the plasmid bearing the BSH gene resulted in a partial restoration of the ability of the mutant strain to use galactose (Fig. 5 ). In conclusion, BSH is capable of partial complementation of the snf5 phenotype in S.cerevisiae. The yeast SNF5p and human INI1 proteins, when tethered to DNA by fusion to the LexA or GAL4 DNA-binding (DB) domain, are capable of activating a reporter gene in yeast cells (30, 31) . To determine whether Arabidopsis BSH was capable of similar activation in yeast cells, we prepared a yeast expression plasmid encoding the GAL4DB-BSH fusion protein. Transformation with this plasmid of the yeast Y190 strain (Clontech) containing the GAL-dependent lacZ reporter did not result in any activation of the lacZ transcription as assayed by measurement of the β-galactosidase activity (results not shown). We confirmed (by western blot with α-GAL4DB antibody) the expression in yeast Y190 strain of the GAL4DB-BSH fusion protein. We also checked that the expression in the reporter strain of a full GAL4 protein resulted in considerable β-galactosidase activity. BSH is thus unable to activate transcription in yeast cells.
Transgenic Arabidopsis plants with significantly reduced physiological level of BSH mRNA display characteristic phenotype
To investigate the possible function of BSH we used the antisense strategy in order to eliminate or considerably reduce the BSH mRNA in plants in vivo. To this end we constructed transgenic plants containing a complete BSH cDNA placed in a reversed orientation under strong non-specific viral promoter. The effect of the expression of this construct was monitored by measuring the level of BSH mRNA in individual transgenic plants. This was done by a slot-blot hybridisation of identical amounts of the total RNA from each plant with the labelled antisense RNA probe specific for BSH mRNA. The level of BSH mRNA was identically determined for the non-transformed plants and for plants transformed with the plasmid not containing the fragment of BSH cDNA (Table 1 ). In ∼25% of plants transformed with the 'antisense' construct the level of BSH mRNA was not considerably changed compared to the control transformed with empty vector (Table 1, plants 2-4) . In the remaining transgenic plants (Table 1 , plants 5-12) the level of BSH mRNA was markedly decreased (5-15% of that in control plants). The decreased level of BSH mRNA was correlated with a bushy phenotype (Fig. 6 ) characterised by reduction in internode length and a decrease in apical dominance. In addition, the flowers of the plants with low level of BSH mRNA had no seeds. An identical correlation between the phenotype of the plants and the decreased level of the BSH mRNA occurred in two independent transformation experiments. The slower electrophoretic mobilities in SDS-PAGE than predicted from sequence analysis was also reported for human and Drosophila homologues of yeast SWI3, another member of SWI/SNF complex (32, 33) . The finding that Arabidopsis BSH gene partially complements the snf5 mutation in S.cerevisiae (Fig. 5) is a strong indication of the functional homology between BSH and yeast SNF5. In contrast to INI1, the BSH, when tethered to DNA, was unable to activate transcription of a reporter gene in yeast. The reason for this is not clear. The transcriptional activation by native SNF5p in such a system could be through recruitment of other members of SWI/SNF complex. However, in yeast cells used to test the BSH (and INI1) activity there was a native SNF5p protein which could make the formation of the heterologous complex rather difficult. It is also possible that the transcription results from the complex-independent activation by SNF5p alone. In this case BSH, in contrast to INI1, would lack such an activity in yeast. It should be noted that the DNA-tethered INI1 could not activate transcription of a reporter gene in human cells (31) .
Human INI1 was identified as a component of a large multiprotein complex homologous to the yeast SWI/SNF complex (13) . Both yeast and human complexes are capable of disrupting nucleosomes and facilitate the binding of transcriptional activators to a nucleosomal template. As regards Drosophila SNR1, it too had been shown to be a component of a large protein complex that also contained the brm protein, a homologue of the yeast SWI2/SNF2 protein (14) .
The human INI1 protein has been shown to interact directly with hbrm (a human homologue of the yeast SWI2/SNF protein) through its conserved SNF5 domain (31) . As there are strong indications of the homology between SWI/SNF-type nucleosome remodelling complexes in yeast, human and Drosophila it is plausible that the SNF5 domains of yeast SNF5 and Drosophila SNR1 are similarly involved in the interactions with SWI2/SNF2 and brm protein, respectively. If this was a general feature of the SNF5 domain one could predict the existence of the Arabidopsis homologue of the yeast SWI2/SNF2 protein. While our search of the Arabidopsis dbEST database (which is now considered to be >70% saturated) for the homologues of yeast SWI2/SNF2 protein rendered no scores, we identified and sequenced (results not shown) a clone with a rare domain characteristic for the SNF2L subfamily of the SNF2 family of proteins (34) . To this subfamily belongs the ISWI protein (35), a component of a different chromatin remodelling complex called NURF, identified in Drosophila embryo extract (36) . We also identified in the database of the A.thaliana genomic sequences two separate genes with high homology to yeast SWI3 protein, another component of the SWI/SNF complex.
The data accumulated so far indicate that in eukaryotic cells, in addition to multiple forms of the SWI/SNF-type complexes (6) , there can exist other complexes with chromatin remodelling activity, like the NURF complex in Drosophila or a recently discovered RSC complex in yeast (37) . It is also evident that in different evolutionary lines the SWI/SNF complexes can be involved in different functions. The human SWI/SNF-type complexes containing either BRG1 or hbrm (homologues of SWI2/SNF2) are not essential for cell viability (38) . However, the Drosophila homologue of SWI/SNF complex seems to be indispensable for normal embryonic development. The homozygosity in mutated snr1 gene encoding the Drosophila homologue of SNF5 was shown to be lethal (14) . In contrast to the spatially and temporary selective expression of snr1 in Drosophila, in Arabidopsis the BSH gene is expressed ubiquitously (Fig. 3A) , a pattern more resembling that reported for expression of the INI1 gene in human tissues (13) . Despite the ubiquitous expression in plant of the BSH mRNA, a considerable decrease of its level achieved by the use of 'antisense' strategy did not cause lethality. However, it resulted in a distinctive change in the morphological appearance (a bushy growth) and in flowers that were unable to produce seeds. This phenotype bears strong resemblance to that of the aux1 mutants of Arabidopsis characterised by resistance to the plant hormone auxin (39) . This may indicate a possible involvement of Arabidopsis BSH in the control of some hormone-responsive genes.
